Inhibition of nuclear factor-κB activation improves non-nitric oxide-mediated cutaneous microvascular function in reproductive-aged healthy women
The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular func...
Saved in:
Published in | American journal of physiology. Heart and circulatory physiology Vol. 327; no. 2; pp. H364 - H369 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.08.2024
|
Series | Vascular Biology and Microcirculation |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.
The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10
−10
to 10
−1
M, 33°C) alone and in combination with 15 mM N
G
-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC
%max
; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.
NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. |
---|---|
AbstractList | The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10-10 to 10-1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women.The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10-10 to 10-1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms.NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 −10 to 10 −1 M, 33°C) alone and in combination with 15 mM N G -nitro- l -arginine methyl ester [ l -NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC %max ; 28 mM sodium nitroprusside + 43°C). The l -NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l -NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l -NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l -NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10−10 to 10−1 M, 33°C) alone and in combination with 15 mM NG-nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC%max; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different (P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 to 10 M, 33°C) alone and in combination with 15 mM -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC ; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both < 0.0001), whereas the l-NAME-sensitive component was not different ( = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate inflammatory mechanisms contributing to accelerated cardiovascular disease risk. However, in the absence of disease, inhibition of NF-κB can impact redox mechanisms, resulting in paradoxically decreased endothelial function. This study aimed to measure microvascular endothelial function during inhibition of the transcriptional regulator NF-κB in reproductive-aged healthy women. In a randomized, single-blind, crossover, placebo-controlled design, nine healthy women were randomly assigned oral salsalate (1,500 mg, twice daily) or placebo treatments for 5 days. Subjects underwent graded perfusion with the endothelium-dependent agonist acetylcholine (ACh, 10 −10 to 10 −1 M, 33°C) alone and in combination with 15 mM N G -nitro-l-arginine methyl ester [l-NAME; nonselective nitric oxide (NO) synthase inhibitor] through intradermal microdialysis. Laser-Doppler flux was measured over each microdialysis site, and cutaneous vascular conductance (CVC) was calculated as flux divided by mean arterial pressure and normalized to site-specific maximum (CVC %max ; 28 mM sodium nitroprusside + 43°C). The l-NAME sensitive component was calculated as the difference between the areas under the dose-response curves. During the placebo and salsalate treatments, the l-NAME sites were reduced compared with the control sites (both P < 0.0001). Across treatments, there was a significant difference between the control and l-NAME sites, where both sites shifted upward following salsalate treatment (both P < 0.0001), whereas the l-NAME-sensitive component was not different ( P = 0.94). These data demonstrate that inhibition of the transcriptional regulator NF-κB improves cutaneous microvascular function in reproductive-aged healthy women through non-NO-dependent mechanisms. NEW & NOTEWORTHY The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in inflammation and impact endothelial function following NF-κB inhibition with salsalate treatment. Our results show that cutaneous microvascular function is increased through non-nitric oxide (NO)-dependent mechanisms following salsalate treatment in reproductive-aged healthy women. |
Author | Williams, Auni C. Content, Virginia G. Alexander, Lacy M. |
Author_xml | – sequence: 1 givenname: Virginia G. orcidid: 0000-0002-5115-3256 surname: Content fullname: Content, Virginia G. organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States – sequence: 2 givenname: Auni C. orcidid: 0000-0001-5439-9182 surname: Williams fullname: Williams, Auni C. organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States – sequence: 3 givenname: Lacy M. orcidid: 0000-0002-1294-8582 surname: Alexander fullname: Alexander, Lacy M. organization: Noll Laboratory, Department of Kinesiology, The Pennsylvania State University, University Park, Pennsylvania, United States, Center for Healthy Aging, The Pennsylvania State University, University Park, Pennsylvania, United States |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38847757$$D View this record in MEDLINE/PubMed |
BookMark | eNpdktFuFCEUholpY7fVJzAxJN54MysMzDBcGW2qNmnSm_aaAHOmy2YGVmBW-xo-jg_RZ5LdbRv1CpLz8eU_h3OKjnzwgNAbSpaUNvUHvd6sQMe8JKQmfFmTmr9Ai1KpK9oweYQWhLWsailrTtBpSmtCSCNa9hKdsK7jQjRigX5d-pUzLrvgcRiwn-1YnHjQNodYPfz-jMvNbfUecNMmhi0kXJJU3uXoLA4_XQ_VBL3TGXps56w9hDnhydkC62TncSecvT04PI5QNP2880Kl78qr0seYV_f4R5jAv0LHgx4TvH48z9Dtl4ub82_V1fXXy_NPV5WtW5krA7U2lLRNZ7pWio5bkI00tLFScgOaG6pJr62RRhApetmTgWptmBgMMEHYGfp48G5mU_Jb8DnqUW2im3S8V0E79W_Fu5W6C1tFKee8rttieP9oiOH7DCmrySUL43gYgWIlnexIs0ff_Yeuwxx96a9QkrSljZYX6u3fkZ6zPP1XAdgBKLNNKcLwjFCidluhnrZC7bdC7baC_QEWMbJq |
Cites_doi | 10.3389/fphys.2020.596507 10.1038/23948 10.1016/j.preghy.2021.12.010 10.1161/01.CIR.101.6.676 10.1017/S0007114516001835 10.1161/JAHA.113.000609 10.1152/ajpregu.00049.2020 10.1152/ajpheart.00368.2021 10.1186/cc9257 10.1161/CIRCULATIONAHA.105.602532 10.1210/jcem.80.3.7883838 10.1007/s10787-023-01242-9 10.2165/00003088-198510020-00004 10.1124/mol.57.4.797 10.1152/japplphysiol.00427.2020 10.1093/emboj/20.21.6008 10.1124/pr.117.014050 10.1038/sj.onc.1209954 10.1249/01.mss.0000150075.81511.fe 10.3389/fragi.2021.727416 10.1002/j.1552-4604.1981.tb01740.x 10.1097/00005344-199322008-00039 10.1111/micc.12490 10.1152/ajpheart.00643.2021 10.1161/01.HYP.33.1.581 10.1126/science.8052854 10.1152/ajpregu.00269.2014 10.1016/0010-7824(95)00210-2 10.1161/CIRCULATIONAHA.108.804294 10.1016/j.mvr.2022.104421 10.1152/ajpheart.00602.2021 10.1113/jphysiol.2009.178822 10.1007/s00592-011-0329-2 10.1016/s0026-0495(00)91039-4 10.1161/01.atv.0000051384.43104.fc 10.1074/jbc.M103702200 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society Aug 2024 Copyright © 2024 the American Physiological Society. 2024 American Physiological Society |
Copyright_xml | – notice: Copyright American Physiological Society Aug 2024 – notice: Copyright © 2024 the American Physiological Society. 2024 American Physiological Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
DOI | 10.1152/ajpheart.00204.2024 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Physical Education Index Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Research Database Toxicology Abstracts Chemoreception Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Technology Research Database MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | NF-κB INHIBITION AND NITRIC OXIDE-INDEPENDENT MECHANISMS |
EISSN | 1522-1539 |
EndPage | H369 |
ExternalDocumentID | PMC11444226 38847757 10_1152_ajpheart_00204_2024 |
Genre | Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) grantid: R01 HL161000-02S2 – fundername: NHLBI NIH HHS grantid: R01 HL161000 – fundername: NHLBI NIH HHS grantid: F31 HL170616 – fundername: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) grantid: F31 HL170616-0 |
GroupedDBID | --- 23M 2WC 39C 4.4 53G 5GY 6J9 AAFWJ AAYXX ABJNI ACBEA ACIWK ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BKOMP BTFSW CITATION E3Z EBS EMOBN F5P H13 ITBOX KQ8 OK1 P2P PQQKQ RAP RHI RPL RPRKH TR2 UKR WH7 WOQ XSW YSK ~02 5VS CGR CUY CVF ECM EIF GX1 NPM W8F 7QP 7QR 7TS 7U7 8FD C1K FR3 P64 7X8 5PM |
ID | FETCH-LOGICAL-c269t-be2ab10658b869784ce959b15c994bea4b1a0dacb9b7097d9d0f1aab37fbe3703 |
ISSN | 0363-6135 1522-1539 |
IngestDate | Thu Aug 21 18:33:20 EDT 2025 Fri Jul 11 02:34:58 EDT 2025 Mon Jun 30 16:45:04 EDT 2025 Sun Aug 03 01:52:46 EDT 2025 Tue Jul 01 02:28:02 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | NO-independent vasodilation NF-κB microdialysis inflammation salsalate |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c269t-be2ab10658b869784ce959b15c994bea4b1a0dacb9b7097d9d0f1aab37fbe3703 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
ORCID | 0000-0001-5439-9182 0000-0002-1294-8582 0000-0002-5115-3256 |
PMID | 38847757 |
PQID | 3090665864 |
PQPubID | 48261 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11444226 proquest_miscellaneous_3065980526 proquest_journals_3090665864 pubmed_primary_38847757 crossref_primary_10_1152_ajpheart_00204_2024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-08-01 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda – name: Rockville, MD |
PublicationSeriesTitle | Vascular Biology and Microcirculation |
PublicationTitle | American journal of physiology. Heart and circulatory physiology |
PublicationTitleAlternate | Am J Physiol Heart Circ Physiol |
PublicationYear | 2024 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | B20 B21 B22 B23 B24 B25 B26 B27 B28 B29 Moncada S (B1) 1991; 43 B30 B31 B10 B32 B11 B33 B12 B34 B13 B35 B14 B36 B15 B37 B16 B38 B17 B18 B19 B3 B4 B5 B6 B7 B8 B9 Hadi HA (B2) 2005; 1 |
References_xml | – ident: B35 doi: 10.3389/fphys.2020.596507 – ident: B6 doi: 10.1038/23948 – ident: B10 doi: 10.1016/j.preghy.2021.12.010 – ident: B24 doi: 10.1161/01.CIR.101.6.676 – ident: B27 doi: 10.1017/S0007114516001835 – volume: 43 start-page: 109 year: 1991 ident: B1 publication-title: Pharmacol Rev – ident: B13 doi: 10.1161/JAHA.113.000609 – ident: B32 doi: 10.1152/ajpregu.00049.2020 – ident: B37 doi: 10.1152/ajpheart.00368.2021 – ident: B31 doi: 10.1186/cc9257 – ident: B4 doi: 10.1161/CIRCULATIONAHA.105.602532 – ident: B26 doi: 10.1210/jcem.80.3.7883838 – ident: B12 doi: 10.1007/s10787-023-01242-9 – ident: B17 doi: 10.2165/00003088-198510020-00004 – ident: B11 doi: 10.1124/mol.57.4.797 – ident: B16 doi: 10.1152/japplphysiol.00427.2020 – ident: B29 doi: 10.1093/emboj/20.21.6008 – ident: B30 doi: 10.1124/pr.117.014050 – volume: 1 start-page: 183 year: 2005 ident: B2 publication-title: Vasc Health Risk Manag – ident: B5 doi: 10.1038/sj.onc.1209954 – ident: B36 doi: 10.1249/01.mss.0000150075.81511.fe – ident: B15 doi: 10.3389/fragi.2021.727416 – ident: B18 doi: 10.1002/j.1552-4604.1981.tb01740.x – ident: B20 doi: 10.1097/00005344-199322008-00039 – ident: B19 doi: 10.1111/micc.12490 – ident: B9 doi: 10.1152/ajpheart.00643.2021 – ident: B21 doi: 10.1161/01.HYP.33.1.581 – ident: B7 doi: 10.1126/science.8052854 – ident: B14 doi: 10.1152/ajpregu.00269.2014 – ident: B34 doi: 10.1016/0010-7824(95)00210-2 – ident: B8 doi: 10.1161/CIRCULATIONAHA.108.804294 – ident: B28 doi: 10.1016/j.mvr.2022.104421 – ident: B38 doi: 10.1152/ajpheart.00602.2021 – ident: B33 doi: 10.1113/jphysiol.2009.178822 – ident: B22 doi: 10.1007/s00592-011-0329-2 – ident: B25 doi: 10.1016/s0026-0495(00)91039-4 – ident: B3 doi: 10.1161/01.atv.0000051384.43104.fc – ident: B23 doi: 10.1074/jbc.M103702200 |
SSID | ssj0005763 |
Score | 2.4540029 |
Snippet | The transcription factor nuclear factor-κB (NF-κB) regulates multiple aspects of innate and adaptive immunity by encoding for genes that participate in... The transcriptional regulator nuclear factor-κB (NF-κB) is a mediator of endothelial dysfunction. Inhibiting NF-κB with salsalate is used to investigate... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | H364 |
SubjectTerms | Acetylcholine - pharmacology Adult Arginine Blood pressure Cardiovascular diseases Cross-Over Studies Endothelium Endothelium, Vascular - drug effects Endothelium, Vascular - metabolism Enzyme Inhibitors - pharmacology Female Health risks Healthy Volunteers Humans Microcirculation - drug effects Microdialysis Microvasculature Microvessels - drug effects Microvessels - metabolism NF-kappa B - metabolism NF-κB protein NG-Nitroarginine methyl ester NG-Nitroarginine Methyl Ester - pharmacology Nitric oxide Nitric Oxide - metabolism Placebos Regional Blood Flow - drug effects Salicylates - pharmacology Short Report Single-Blind Method Skin - blood supply Skin - drug effects Skin - metabolism Sodium nitroprusside Transcription activation Vasodilation - drug effects Vasodilator Agents - pharmacology Young Adult |
Title | Inhibition of nuclear factor-κB activation improves non-nitric oxide-mediated cutaneous microvascular function in reproductive-aged healthy women |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38847757 https://www.proquest.com/docview/3090665864 https://www.proquest.com/docview/3065980526 https://pubmed.ncbi.nlm.nih.gov/PMC11444226 |
Volume | 327 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLbKkKbdINj4KQxkJMYVKflx0viynYYKaAikDe0uimOXBalpFVqJ8hg8DuIZeCbOsR0nXYcE3ERVbMVRvy_H59jnfCbkmZQJUz6XHs-HvsdCEXsilIUnpwr8OV-xQmt3nr5LJufszUV80ev97GQtrZZiUHy7tq7kf1CFe4ArVsn-A7LuoXADfgO-cAWE4fpXGL-uLktRNj5fhdLEeW2P0PGOjk-OxqOxVssw665YElnPUWYWYn4PvmXMop9_LaXydAEJOp_FCrxFhXmxM0zVc4mqOP81eZEohKl1YsFSemCPpK2mXBs9h66_6zaEOgoVejFFr-YPsAqqNjnuRVnjSHrPv-3htkhQRMtIJHws608l1pK5U8G6a0ajVVW2K7-ufMeUgBdru_hrlzlC5pLsYJayphnCZrDPvGu7IyMsYEkadizxJDLq6NtTRIySs_nnBZ4Yvhzo6uABjtjtDTgvZpo1UQrz99CIaF9R5m6abpCbIQQpeH7G2w-tVj1EcpHVuYIxX14z4h7ZbZ6x6RZtxTpXU3Y7PtDZbXLLBi90ZJh4h_RUtU8ORhWgNlvT5_S9w22f7J7arI0D8r3lKZ1PqeUptTz99WNMW47ShqO05Sjd5Ch1HKUbHKUNR2lZ0S2OUstRqjl6l5y_Ojk7nnj2LBCvCBO-9IQKcxGgvyzShA9TVigecxHEBedMqJyJIPdlXgguhj4fSi79aZDnIhpOhYpgWrtHduC91QNCoyCPIslDNU0UY1LmsvDzQIgUrJME29QnLxoosoWRfMl0qByHWQNipkHMEMQ-OWzgyuy39CWLfI57mmkCzU9dM1hu3I4zfxH0SWKOJ4okfXLfoOvGa2jRJ-kG7q4DqsJvtlTlpVaHDwLGsDz-4R8f-ojstV_YIdlZ1iv1GFzrpXiiGfwb337eLg |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inhibition+of+nuclear+factor-%CE%BAB+activation+improves+non-nitric+oxide-mediated+cutaneous+microvascular+function+in+reproductive-aged+healthy+women&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Content%2C+Virginia+G&rft.au=Williams%2C+Auni+C&rft.au=Alexander%2C+Lacy+M&rft.date=2024-08-01&rft.eissn=1522-1539&rft.volume=327&rft.issue=2&rft.spage=H364&rft_id=info:doi/10.1152%2Fajpheart.00204.2024&rft_id=info%3Apmid%2F38847757&rft.externalDocID=38847757 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon |